Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Citigroup Upgrades ResMed to Buy

Citigroup analyst John Deakin-Bell upgrades ResMed (NYSE:RMD) from Neutral to Buy.

September 8, 2022

1 minute read

Citigroup analyst John Deakin-Bell upgrades ResMed (NYSE:RMD) from Neutral to Buy.

Cowen & Co. Initiates Coverage On Allakos with Outperform Rating

Today, 6:20 AM

Cowen & Co. analyst Joseph Thome initiates coverage on Allakos (NASDAQ:ALLK) with a Outperform rating.

Today, 6:20 AM

Tesla Inc.’s (NASDAQ: TSLA) China sales is picking up momentum, although it continues to trail behind

Today, 6:20 AM

Cedar Fair LP (NYSE:FUN) reported second-quarter FY21 net revenues of $224.137 million, versus the consensus of $224.50 million. It reported $7…

Today, 6:20 AM

Shares of Alibaba Group Holding Limited (NYSE: BABA), JD.Com Inc. (NASDAQ: JD), Tencent Holdings Inc.